Randomized proof of concept trial of GLYX-13, an N -methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent
Fatigue, brain fog, poor sleep, and mood shifts can tag along when the gut is inflamed
Explore our detailed BPC-157 research guide for a complete overview of the literature
To help preserve muscle, patients are advised to combine peptide therapy with resistance training and adequate protein intake (STEP 1 body composition analysis)
Growth-Factor Signaling and Tissue Repair BPC 157 appears to influence growth factors involved in healing, including vascular endothelial growth factor, or VEGF
Since Ruminiclostridium 6 was only observed in the LD control group, it was unsurprising that its relative abundance was significantly greater in this group compared to all other experimental groups (Supplementary Fig